A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formationJohn T. Brandt, Kenneth J. Winters, Christopher D. Payne et al.|American Heart Journal|2006Cited by 571
Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose ClopidogrelChristopher D. Payne, Kenneth J. Winters, Ying Grace Li et al.|Journal of Cardiovascular Pharmacology|2007Cited by 167
The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administrationChristopher D. Payne, Joseph A. Jakubowski, Ying G. Li et al.|Thrombosis and Haemostasis|2008Cited by 120
Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly PatientsDavid Erlinge, Dominick J. Angiolillo, Paul A. Gurbel et al.|Journal of the American College of Cardiology|2013Cited by 94
The Platelet Inhibitory Effects and Pharmacokinetics of Prasugrel After Administration of Loading and Maintenance Doses in Healthy SubjectsJoseph A. Jakubowski, Kenneth J. Winters, Christopher D. Payne et al.|Journal of Cardiovascular Pharmacology|2006Cited by 89